Genomics market on the rise

The genomics market is expected to grow at an annual compound growth rate of 7.28 percent from 2013 to 2018, according to a recent market report from market research firms Infiniti Research Limited and TechNavio.    

The market includes all technology related to the study of genomes, whether that be the mapping of genomic structures or identifying the function of specific genes. This includes comparative genomics, sequencing and genomic analysis.

Cutting-edge sequencing systems, polymerase chain reaction systems and microarrays are among the technologies being applied for the increased use of genomic research for purposes of diagnostic testing and drug development.

Bio-Rad Laboratories, F. Hoffman-La Roche, Illumina, Qiagen and Thermo Fisher Scientific are the market leaders in genomic research and technology, according to TechNavio analysts.
 

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.